The Global Nano Robotics Market is predicted to reach US$ 19.86 Billion with the aid of 2032, developing at a CAGR of 11.34% from 2024 to 2032. According to the report, Nano Robotics Market was worth US$ 7.55 Billion in 2023.
Nanorobotics is a field of robotics that involves designing and controlling robots at the nanoscale. Nanorobots have precise properties that allow them to govern substances and carry out duties beyond the abilities of conventional robots. Advances in materials science, nanotechnology, and pc engineering have pushed the development of nanorobotics. Nanorobots have several promising medical programs, consisting of drug shipping, ailment diagnosis, and tissue restoration. They also can be utilized in environmental tracking and growing new materials.
Advancements in nanotechnology: Nanorobots have the capability to revolutionize healthcare. They can deliver medicines to specific cells or locations, carry out minimally invasive surgeries, invest in unique tissue restoration, and carry out molecular diagnostics. In February 2021, TESCAN released a nanomanipulator designed to assist in TEM sample lift-out and micro- and nanoscale manipulation below room temperature and cryo situations.
Focus on Regenerative Medicine: The nanorobotics marketplace is predicted to grow due to the focus on regenerative medication. This field makes a specialty of developing treatments to restore, update, or regenerate damaged cells, tissues, and organs. Nanorobotics may be harnessed to improve the development of regenerative remedies, offering promising possibilities for tissue restoration and regeneration. The global financing of regenerative medicinal drugs has increased to USD 22.7 billion in 2021 from USD 19.9 billion. This financing is being used to aid 2,406 products that are under investigation. The rising consciousness of regenerative medication is driving the growth of the nanorobotics marketplace.
Governments, private institutions, and company investment: Innovation thrives on financial support, empowering researchers to explore new possibilities and commercial applications. A prime example is Nanobots Therapeutics, a technology company that recently closed a Pre-Seed funding round of €478,000 (US$ 504,185) to develop and commercialize their MotionTx platform. The startup specializes in creating biocompatible nanorobots that deliver drugs to difficult-to-treat tumors more efficiently and safely than current therapies.
NanobotsTherapeutics was selected as the third investment in the fifth edition of Banco Sabadell's BStartup Health program received 127 startup applications. Google and GlaxoSmithKline have partnered to form a nanobot powerhouse that will showcase the significance of nanorobotics in the future. French startup Eligo has raised US$ 27.4 Million to put protein-based nanobots in the bowels and is now moving clinical programs into humans.
2. Nano-Surgery Robots
3. Magnetically Guided Nanorobots
4. Bacteria-Based Nanorobots
5. DNA-Based Nanorobots
6. Molecular Nanorobots
2. Biomedical
3. Drug Delivery
4. Medical Imaging
5. Others
1.1 United States
1.2 Canada
2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherlands
2.8 Turkey
3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand
4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
5. Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 South Africa
2. Thermo Fisher Scientific
3. Bruker Corporation
4. JEOL Ltd
5. Agilent Technologies, Inc.
6. Ginkgo Bio Works
7. Park Systems
8. Imina Technologies
Nanorobotics is a field of robotics that involves designing and controlling robots at the nanoscale. Nanorobots have precise properties that allow them to govern substances and carry out duties beyond the abilities of conventional robots. Advances in materials science, nanotechnology, and pc engineering have pushed the development of nanorobotics. Nanorobots have several promising medical programs, consisting of drug shipping, ailment diagnosis, and tissue restoration. They also can be utilized in environmental tracking and growing new materials.
Global Nano Robotics Market Trends
The upward incidence of chronic diseases and the need for particular and customized treatments: Non-communicable diseases (NCDs) are responsible for 74 percent of all global fatalities, causing 41 million deaths a year. Seventeen million individuals die from a continual ailment before attaining the age of 70, and the bulk of those deaths arise in low- and middle-income economies. Nanorobots are increasingly in demand inside the healthcare industry to provide unique and customized remedies for persistent diseases.Advancements in nanotechnology: Nanorobots have the capability to revolutionize healthcare. They can deliver medicines to specific cells or locations, carry out minimally invasive surgeries, invest in unique tissue restoration, and carry out molecular diagnostics. In February 2021, TESCAN released a nanomanipulator designed to assist in TEM sample lift-out and micro- and nanoscale manipulation below room temperature and cryo situations.
Focus on Regenerative Medicine: The nanorobotics marketplace is predicted to grow due to the focus on regenerative medication. This field makes a specialty of developing treatments to restore, update, or regenerate damaged cells, tissues, and organs. Nanorobotics may be harnessed to improve the development of regenerative remedies, offering promising possibilities for tissue restoration and regeneration. The global financing of regenerative medicinal drugs has increased to USD 22.7 billion in 2021 from USD 19.9 billion. This financing is being used to aid 2,406 products that are under investigation. The rising consciousness of regenerative medication is driving the growth of the nanorobotics marketplace.
Governments, private institutions, and company investment: Innovation thrives on financial support, empowering researchers to explore new possibilities and commercial applications. A prime example is Nanobots Therapeutics, a technology company that recently closed a Pre-Seed funding round of €478,000 (US$ 504,185) to develop and commercialize their MotionTx platform. The startup specializes in creating biocompatible nanorobots that deliver drugs to difficult-to-treat tumors more efficiently and safely than current therapies.
NanobotsTherapeutics was selected as the third investment in the fifth edition of Banco Sabadell's BStartup Health program received 127 startup applications. Google and GlaxoSmithKline have partnered to form a nanobot powerhouse that will showcase the significance of nanorobotics in the future. French startup Eligo has raised US$ 27.4 Million to put protein-based nanobots in the bowels and is now moving clinical programs into humans.
Asia Pacific Nano Robotics Market
The nanorobots market is anticipated to witness significant growth in the Asia-Pacific region owing to the swift progress in nanotechnology and the availability of research and development prospects in emerging economies such as India and China. The governments of countries like Japan and China exhibit active involvement in research and development activities, promoting innovation and facilitating the acceptance of nanorobotic technologies. The potential of nanoscale industrial robots in China for manufacturing and producing nanomaterials with precision and accuracy is discussed. In Japan, JEOL's InTouchScope SEM JSM-IT200 series has been launched. It comes in four configurations, each equipped with different capabilities. SurfRider's 'HQ-Series' of budget-priced AFM probes and Asylum Research's model suitable for nanomechanical imaging are also mentioned.Global Nano Robotics Market Company News
The global nanorobotics market comprises key companies like Oxford Instruments, Thermo Fisher Scientific, Bruker Corporation, JEOL Ltd, Agilent Technologies, Inc., Ginkgo Bio Works, Park Systems, and Imina Technologies.- In February 2023, Ginkgo Bioworks and Bioweg entered into a partnership to enhance the manufacturing process of bacterial cellulose and create novel cellulose variations with improved performance for diverse markets.
- JEOL Ltd. released the 'JIB-PS500i' FIB-SEM system in February 2023. This system provides higher resolution and precision for morphological observation and elemental analysis of new materials due to their finer structure and increased complexity of operations.
- Nanobots Therapeutics, a spin-off created by IBEC and ICREA, aims to develop and commercialize the MotionTx platform, which uses nanorobots with unique tumor penetration capabilities. The technology is expected to be ready by February 2023.
- April 2022, Nanovery, a biotechnology research company, has recently secured over £1.85 million in funding to support its mission of developing more accurate testing for chronic illnesses such as prostate cancer and liver disease. The company's nanorobot platform can detect such infections, and its innovations can be applied to various sectors, including pre-clinical drug development, life sciences, agriculture bio, and food safety.
- TESCAN Orsay Holding has released the TESCAN Nanomanipulator. This solution enables lift-out and micro- and nanoscale manipulation under room-temperature and cryo conditions on TESCAN SEM and FIB-SEM instruments. It was launched in February 2021.
- Bionaut Labs announced in March 2021 that it had secured US$ 20 Million in funding in a financing round led by Khosla Ventures and Upfront Ventures. Bionaut Labs is developing nanorobots that can administer drugs to treat brain diseases.
Product Type - Global Nano Robotics Market breakup in 6 viewpoints:
1. Bio-Nanorobots2. Nano-Surgery Robots
3. Magnetically Guided Nanorobots
4. Bacteria-Based Nanorobots
5. DNA-Based Nanorobots
6. Molecular Nanorobots
Application - Global Nano Robotics Market breakup in 5 viewpoints:
1. Nanomedicine2. Biomedical
3. Drug Delivery
4. Medical Imaging
5. Others
Country - Global Nano Robotics Market breakup of 25 Countries Covered in the Report:
1. North America1.1 United States
1.2 Canada
2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherlands
2.8 Turkey
3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand
4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
5. Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 South Africa
All the key players have been covered from 3 viewpoints:
- Overview
- Recent Development
- Revenue Analysis
Company Analysis:
1. Oxford Instruments2. Thermo Fisher Scientific
3. Bruker Corporation
4. JEOL Ltd
5. Agilent Technologies, Inc.
6. Ginkgo Bio Works
7. Park Systems
8. Imina Technologies
Table of Contents
1. Introduction2. Research Methodology3. Executive Summary5. Global Nanobots Market
4. Market Dynamics
6. Market Share - Global Nanobots Market
7. Product Type - Global Nanobots Market
8. Application - Global Nanobots Market
9. Country - Global Nanobots Market
10. Porter’s Five Analysis - Global Nanobots Market
11. SWOT Analysis - Global Nanobots Market
12. Company Analysis
List of Figures
List of Tables
Companies Mentioned
- Oxford Instruments
- Thermo Fisher Scientific
- Bruker Corporation
- JEOL Ltd
- Agilent Technologies, Inc.
- Ginkgo Bio Works
- Park Systems
- Imina Technologies
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 190 |
| Published | April 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 7.55 Billion |
| Forecasted Market Value ( USD | $ 19.86 Billion |
| Compound Annual Growth Rate | 11.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 8 |
